All In Biotech

Drug Trial Radar · NCT03236246

KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)

Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia

Last checked: Nov 20, 2026Latest source record: Mar 12, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 206 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

206

Actual

Start

Aug 15, 2017

Primary completion

Aug 30, 2019

Study completion Sep 27, 2019

Sponsor

Lead sponsor
Keryx BiopharmaceuticalsIndustry
Sponsor type
Industry
First posted
Aug 1, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objectives of this study are to assess the long-term efficacy and safety of different dose regimens of KRX-0502 in the treatment of iron deficiency anemia (IDA) in adult subjects with non-dialysis dependent chronic kidney disease (CKD).

Conditions

  • Chronic Kidney Diseases
  • Iron Deficiency Anemia

Interventions

  • KRX-0502Drug

    Oral ferric citrate with meals

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Hemoglobin (Hgb) at Week 24Time frame: Baseline; Week 24

Locations

28 sites in 1 country. Site status is shown where the registry gives one.

  • Arizona Kidney Disease and Hypertension center: AKDHC Medical Research Services, LLC

    Phoenix, Arizona

  • California Institute of Renal Research

    Chula Vista, California

  • California Institute of Renal Research

    El Centro, California

  • California Institute of Renal Research

    Poway, California

  • Denver Nephrologists, P.C.

    Denver, Colorado

  • Miami Kidney Group

    Miami, Florida

  • Kidney and Hypertension Specialists of Miami, P.A.

    Miami, Florida

  • Southeastern Clinical Research Institute, LLC

    Augusta, Georgia

  • Renal Associates, LLC

    Columbus, Georgia

  • Research by Design, LLC

    Chicago, Illinois

  • South Mississippi Medical Research, LLC

    Gulfport, Mississippi

  • Clinical Research Consultants

    Kansas City, Missouri

  • Sierra Nevada Nephrology Consultants

    Reno, Nevada

  • Hypertension and Nephrology Association

    Eatontown, New Jersey

  • Division of Kidney/HTN Research

    Great Neck, New York

  • Mountain Kidney & Hypertension Associates

    Asheville, North Carolina

  • Metrolina Nephrology Associates, PA

    Charlotte, North Carolina

  • Eastern Nephrology Associates

    Greenville, North Carolina

  • Southeastern Nephrology Associates

    Jacksonville, North Carolina

  • Eastern Nephrology Associates

    New Bern, North Carolina

  • Southeastern Nephrology

    Wilmington, North Carolina

  • Columbia Nephrology Associates, PA

    Columbia, South Carolina

  • South Carolina Nephrology & Hypertension Center, Inc

    Orangeburg, South Carolina

  • Nephrology Associates, P.C.

    Nashville, Tennessee

  • Research Management, Inc.

    Austin, Texas

  • Research Management, Inc.

    Austin, Texas

  • P & I Clinical Research, LLC

    Lufkin, Texas

  • Clinical Advancement Center, PLLC

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.